Dr. Corinna Levine, MD

Dr. Levine practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Levine's NPI, 1972768133, was assigned on July 26, 2008. Dr. Levine graduated from Yale School of Medicine in 2008. Dr. Levine holds Florida license ME123526.

Dr. Levine's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Levine's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Levine to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levine practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Levine's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Levine is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Levine is licensed in Florida.

Dmand AI lists acute sinusitis, chronic sinusitis and endoscopic sinus surgery among the conditions Dr. Levine treats.

CMS data shows 173 Medicare services from Dr. Levine across 5 procedure codes in 2024, for 67 Medicare patients. Medicare paid $19,058 for them.

CMS counts 67 Medicare patients who saw Dr. Levine in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Levine's median patient age at 67, with 48% women.

In 2024, Dr. Levine wrote 185 Medicare Part D claims for 58 patients. 96% of them were for generic drugs. CMS names the drug for 131 of them, across 5 drugs with 11 or more claims each, at $2,715 in total drug cost. In 2023, CMS named 154 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Levine for performance year 2024, reported as part of a group. Dr. Levine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Levine as offering telehealth.

Dmand AI links 39 papers to Dr. Levine, published from 2004 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Rhinitis, Sinusitis and Endoscopy. Dr. Levine has published most often in Int Forum Allergy Rhinol. Dr. Levine's most frequent co-authors are Roy R. Casiano, MD, Richard Rosenfeld, MD and Nithin Dev Adappa, MD.

CMS Open Payments shows 77 general payments to Dr. Levine from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Sanofi and Genzyme US Companies paid the most, $11,032. It also lists 9 research payments totaling $1,482 in 2025, naming 1 clinical trial.

Dr. Levine graduated from Yale School of Medicine in 2008.

Dr. Levine is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.